Inflazyme Pharmaceuticals Ltd.
TSX : IZP

Inflazyme Pharmaceuticals Ltd.

October 12, 2005 18:40 ET

Inflazyme to Present at 2005 BIO InvestorForum

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Oct. 12, 2005) - Inflazyme Pharmaceuticals Ltd. (TSX:IZP) announced today that it will present at the BIO InvestorForum on Thursday, October 20, 2005 at 10:00 a.m. Pacific Time at The Palace Hotel in San Francisco, California. Dr. Kevin Mullane, President and CEO of Inflazyme, will provide a business overview and discuss the Company's product pipeline.

A live audio broadcast and subsequent archived recording of Dr. Mullane's presentation will be available on Inflazyme's website at www.inflazyme.com under the Investors section.

Inflazyme Pharmaceuticals is a biopharmaceutical company pioneering medical breakthroughs that will transform the lives of patients with respiratory and inflammatory diseases worldwide. Further information on the Company may be obtained from its website at www.inflazyme.com.

Statements in this news release other than historical information are forward-looking statements subject to risks and uncertainties. Actual results could differ materially depending on factors such as the availability of resources, the timing and effects of regulatory actions, the strength of competition, the outcome of litigation and the effectiveness of patent protection. Additional information regarding risks and uncertainties is set forth in the current Annual Information Form for Inflazyme on file with the Canadian Securities Commissions.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this information.

Contact Information